Premium
MeiraGTx Holdings PLC (MGTX)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-19 | Dr. Alexandria ForbesCEO, President & Director | -62,00k | 568,54k | Automatic Disposition | 9,17 | 1,39M | -4,28% |
| 2026-01-07 | Dr. Robert K. ZeldinChief Medical Officer | -7,81k | 60,40k | Sale to Issuer | 7,73 | 146,20k | -5,07% |
| 2026-04-21 | Mr. Richard Brian GirouxCOO & CFO | -56,00k | 572,32k | Automatic Disposition | 10,22 | 1,06M | -5,01% |
| 2026-04-07 | Dr. Stuart NaylorChief Scientific Officer of Ophthalmology | -27,66k | 258,91k | Automatic Disposition | 9,36 | 668,51k | -3,97% |
| 2026-03-24 | Dr. Alexandria ForbesCEO, President & Director | -62,00k | 459,42k | Automatic Disposition | 7,41 | 1,45M | -4,10% |
| 2026-02-21 | Dr. Robert K. ZeldinChief Medical Officer | 4,55k | 0,00 | Derivative Exercise and Retained Stock | - | 172,89k | 2,70% |
| 2026-02-21 | Dr. Robert K. ZeldinChief Medical Officer | -2,95k | 21,99k | Derivative Exercise and Sale | 7,45 | 172,89k | - |
| 2026-02-21 | Mr. Robert J. WollinGeneral Counsel & Secretary | 5,30k | 0,00 | Derivative Exercise and Retained Stock | - | 57,38k | 10,18% |
| 2026-02-21 | Mr. Robert J. WollinGeneral Counsel & Secretary | -5,95k | 44,32k | Derivative Exercise and Sale | 7,45 | 57,38k | - |
| 2026-02-21 | Dr. Stuart NaylorChief Scientific Officer of Ophthalmology | 13,25k | 0,00 | Derivative Exercise and Retained Stock | - | 696,17k | 1,94% |
| 2026-02-21 | Dr. Stuart NaylorChief Scientific Officer of Ophthalmology | -11,75k | 87,54k | Derivative Exercise and Sale | 7,45 | 696,17k | - |
| 2026-02-21 | Mr. Richard Brian GirouxCOO & CFO | 28,27k | 0,00 | Derivative Exercise and Retained Stock | - | 1,12M | 2,60% |
| 2026-02-21 | Mr. Richard Brian GirouxCOO & CFO | -31,73k | 236,36k | Derivative Exercise and Sale | 7,45 | 1,12M | - |
| 2026-02-21 | Dr. Alexandria ForbesCEO, President & Director | 29,45k | 0,00 | Derivative Exercise and Retained Stock | - | 1,51M | 1,99% |
| 2026-02-21 | Dr. Alexandria ForbesCEO, President & Director | -33,05k | 246,21k | Derivative Exercise and Sale | 7,45 | 1,51M | - |
| 2026-01-17 | Dr. Robert K. ZeldinChief Medical Officer | 21,05k | 0,00 | Derivative Exercise and Retained Stock | - | 168,34k | 14,29% |
| 2026-01-17 | Dr. Robert K. ZeldinChief Medical Officer | -13,95k | 103,52k | Derivative Exercise and Sale | 7,42 | 168,34k | - |
| 2026-01-17 | Mr. Robert J. WollinGeneral Counsel & Secretary | 22,79k | 0,00 | Derivative Exercise and Retained Stock | - | 52,08k | 77,84% |
| 2026-01-17 | Mr. Robert J. WollinGeneral Counsel & Secretary | -27,21k | 201,87k | Derivative Exercise and Sale | 7,42 | 52,08k | - |
| 2026-01-17 | Dr. Stuart NaylorChief Scientific Officer of Ophthalmology | 39,75k | 0,00 | Derivative Exercise and Retained Stock | - | 682,92k | 6,18% |
| 2026-01-17 | Dr. Stuart NaylorChief Scientific Officer of Ophthalmology | -35,25k | 261,56k | Derivative Exercise and Sale | 7,42 | 682,92k | - |
| 2026-01-17 | Mr. Richard Brian GirouxCOO & CFO | 146,08k | 0,00 | Derivative Exercise and Retained Stock | - | 1,09M | 15,49% |
| 2026-01-17 | Mr. Richard Brian GirouxCOO & CFO | -163,92k | 1,22M | Derivative Exercise and Sale | 7,42 | 1,09M | - |
| 2026-01-17 | Dr. Alexandria ForbesCEO, President & Director | 146,08k | 0,00 | Derivative Exercise and Retained Stock | - | 1,48M | 10,93% |
| 2026-01-17 | Dr. Alexandria ForbesCEO, President & Director | -163,92k | 1,22M | Derivative Exercise and Sale | 7,42 | 1,48M | - |
| 2026-01-07 | Dr. Robert K. ZeldinChief Medical Officer | 17,50k | 0,00 | Derivative Exercise and Retained Stock | - | 146,20k | 13,60% |
| 2026-01-07 | Mr. Robert J. WollinGeneral Counsel & Secretary | 3,14k | 0,00 | Derivative Exercise and Retained Stock | - | 29,28k | 11,99% |
| 2026-01-07 | Mr. Robert J. WollinGeneral Counsel & Secretary | -4,36k | 33,73k | Derivative Exercise and Sale | 7,73 | 29,28k | - |
| 2026-01-07 | Dr. Stuart NaylorChief Scientific Officer of Ophthalmology | 19,88k | 0,00 | Derivative Exercise and Retained Stock | - | 643,17k | 3,19% |
| 2026-01-07 | Dr. Stuart NaylorChief Scientific Officer of Ophthalmology | -17,63k | 136,24k | Derivative Exercise and Sale | 7,73 | 643,17k | - |
| 2026-01-07 | Mr. Richard Brian GirouxCOO & CFO | 23,68k | 0,00 | Derivative Exercise and Retained Stock | - | 943,32k | 2,57% |
| 2026-01-07 | Mr. Richard Brian GirouxCOO & CFO | -28,82k | 222,79k | Derivative Exercise and Sale | 7,73 | 943,32k | - |
| 2026-01-07 | Dr. Alexandria ForbesCEO, President & Director | 28,43k | 0,00 | Derivative Exercise and Retained Stock | - | 1,34M | 2,17% |
| 2026-01-07 | Dr. Alexandria ForbesCEO, President & Director | -34,07k | 263,39k | Derivative Exercise and Sale | 7,73 | 1,34M | - |
| 2025-12-31 | Perceptive Advisors LLCSociété | -2,30M | 18,19M | Sale to Issuer | 7,91 | 10,23M | -18,35% |
| 2025-12-23 | Dr. Alexandria ForbesCEO, President & Director | -6,25k | 0,00 | Other Disposition | - | 1,31M | -0,48% |
| 2025-11-20 | Mr. Robert J. WollinGeneral Counsel & Secretary | -5,00k | 0,00 | Other Disposition | - | 26,15k | -16,05% |
| 2025-10-21 | Mr. Richard Brian GirouxCOO & CFO | -24,00k | 212,88k | Automatic Disposition | 8,87 | 919,65k | -2,54% |
| 2025-10-07 | Dr. Alexandria ForbesCEO, President & Director | -47,50k | 398,53k | Automatic Disposition | 8,39 | 1,31M | -3,49% |
| 2025-07-22 | Mr. Richard Brian GirouxCOO & CFO | -24,00k | 204,48k | Automatic Disposition | 8,52 | 943,65k | -2,48% |
| 2025-07-08 | Dr. Alexandria ForbesCEO, President & Director | -47,50k | 378,58k | Automatic Disposition | 7,97 | 1,36M | -3,37% |
| 2025-06-30 | Mr. Richard Brian GirouxCOO & CFO | -5,00k | 0,00 | Other Disposition | - | 967,65k | -0,51% |
| 2025-06-06 | Dr. Keith Reginald HarrisIndependent Chairman of the Board | 75,00k | 0,00 | Derivative Exercise and Retained Stock | - | 125,00k | 150,00% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
